Regpara

Regpara

Manufacturer:

Kyowa Kirin

Distributor:

DCH Auriga - Healthcare
/
Four Star
Concise Prescribing Info
Contents
Cinacalcet HCl
Indications/Uses
Secondary hyperparathyroidism in patients undergoing maintenance dialysis.
Dosage/Direction for Use
Initially 25 mg once daily, may be adjusted to 25-75 mg once daily. Increase dose by 25 mg at 3-wk intervals up to 100 mg once daily if required or if there is no improvement on the parathyroid hormone (PTH).
Administration
May be taken with or without food: May be taken w/ meals for better absorption.
Contraindications
Special Precautions
Determine serum Ca & PTH level prior to & periodically during therapy. Decrease dose as needed if serum Ca level is ≤8.4 mg/dL or w/draw if ≤7.5 mg/dL. Hypocalcemia, seizure, hepatic dysfunction, GI hemorrhage &/or ulcer, adynamic bone disease, hungry bone syndrome. Patients not on dialysis. Pregnancy & lactation. Infant & childn. Elderly.
Adverse Reactions
GI disturbances, hypocalcaemia, prolonged QT interval, decreased level or temporary loss of consciousness.
Drug Interactions
Azole antifungals, macrolides, amiodarone HCl, grapefruit juice, TCAs, butyrophenone antipsychotics, flecainide, vinblastine, calcitonin, bisphosphonates, corticosteroids, digitoxin, diazepam.
ATC Classification
H05BX01 - cinacalcet ; Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.
Presentation/Packing
Form
Regpara film-coated tab 25 mg
Packing/Price
100's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in